← Back to Search

Diabetes Management App for Diabetes (GEMApp Trial)

N/A
Waitlist Available
Research Sponsored by Marshall University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Type 1 or type 2 diabetes on therapeutic treatment other than just lifestyle changes
Be older than 18 years old
Must not have
Cognitive impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months

Summary

This trial is testing whether a phone app can help manage diabetes and improve A1C levels and quality of life.

Who is the study for?
This trial is for individuals with type 1 or type 2 diabetes who are under treatment by the Marshall Internal Medicine Department. Participants must have a smartphone and at least a sixth-grade education level. Pregnant women and those with cognitive impairments cannot join.
What is being tested?
The study tests an app that gives instructions for managing blood sugar levels to see if it can improve diabetic care, reduce emergency room visits, better A1C levels (a measure of blood sugar control), and enhance quality of life compared to general advice.
What are the potential side effects?
Since this trial involves using an app for glucose management guidance rather than medication, there are no direct medical side effects. However, potential issues may include stress or confusion from app usage.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am being treated for diabetes with medication, not just diet or exercise.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have difficulty with memory or thinking clearly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
ADDQOL score

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Functioning AppExperimental Treatment1 Intervention
These subjects have the complete algorithm functioning and communicated via the App.
Group II: Non-functioning AppPlacebo Group1 Intervention
These subjects receive routine instructions via the App but not the complete algorithm.

Find a Location

Who is running the clinical trial?

Marshall UniversityLead Sponsor
20 Previous Clinical Trials
3,890 Total Patients Enrolled

Media Library

Experimental Group instructions for glucose management via App Clinical Trial Eligibility Overview. Trial Name: NCT02336217 — N/A
Diabetes Research Study Groups: Non-functioning App, Functioning App
Diabetes Clinical Trial 2023: Experimental Group instructions for glucose management via App Highlights & Side Effects. Trial Name: NCT02336217 — N/A
Experimental Group instructions for glucose management via App 2023 Treatment Timeline for Medical Study. Trial Name: NCT02336217 — N/A
~5 spots leftby Jun 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top